HST Global Inc. Revenue per Share

Revenue per Share of HSTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including Revenue per Share growth rates and interactive chart. Calculated as total revenue divided by the number of weighted average shares outstanding in the period. It can be easily compared to the stock price to determine how revenue is an investor getting for every $1 paid for a stock.


Highlights and Quick Summary

  • Revenue per Share for the quarter ending June 29, 2020 was 0.0 (a NaN% decrease compared to previous quarter)
  • Year-over-year quarterly Revenue per Share decreased by NaN%
  • Annual Revenue per Share for 2019 was 0.0 (a NaN% decrease from previous year)
  • Annual Revenue per Share for 2018 was 0.0 (a NaN% decrease from previous year)
  • Annual Revenue per Share for 2017 was 0.0 (a NaN% decrease from previous year)
  • Twelve month Revenue per Share ending June 29, 2020 was 0.0 (a NaN% decrease compared to previous quarter)
  • Twelve month trailing Revenue per Share decreased by NaN% year-over-year
Trailing Revenue per Share for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
0.0 0.0 0.0 0.0
Visit stockrow.com/HSTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Revenue per Share of HST Global Inc.

Most recent Revenue per Shareof HSTC including historical data for past 10 years.

Interactive Chart of Revenue per Share of HST Global Inc.

HST Global Inc. Revenue per Share for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 0.0 0.0
2019 0.0 0.0 0.0 0.0 0.0
2018 0.0 0.0 0.0 0.0 0.0
2017 0.0 0.0 0.0 0.0 0.0
2016 0.0 0.0 0.0 0.0 0.0
2015 0.0 0.0 0.0 0.0 0.0
2014 0.0 0.0 0.0 0.0 0.0
2013 0.0 0.0 0.0 0.0 0.0
2012 0.0 0.0 0.0 0.0 0.0
2011 0.0 0.0 0.0 0.0 0.0
2010 0.0 0.0 0.0 0.0 0.0
2009 0.0 0.0

Business Profile of HST Global Inc.

Sector: Medical
Industry: Drugs
HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer worldwide. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancers and other life threatening diseases. The company also intends to acquire products for the treatment of individual health challenges. HST Global, Inc. is headquartered in Hampton, Virginia.